The use of novel humanized mouse model for the study of immunotherapy against HTLV-1 infection
Project/Area Number |
21590512
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Single-year Grants |
Section | 一般 |
Research Field |
Virology
|
Research Institution | University of the Ryukyus |
Principal Investigator |
SAITO Mineki 琉球大学, 大学院・医学研究科, 准教授 (40398285)
|
Co-Investigator(Kenkyū-buntansha) |
TANAKA Yuetsu 琉球大学, 大学院・医学研究科, 教授 (30163588)
|
Project Period (FY) |
2009 – 2011
|
Project Status |
Completed (Fiscal Year 2011)
|
Budget Amount *help |
¥4,680,000 (Direct Cost: ¥3,600,000、Indirect Cost: ¥1,080,000)
Fiscal Year 2011: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2010: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2009: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
|
Keywords | 感染防御 / ワクチン / ヒト化マウス / HTLV-1 / 免疫学 / HAM |
Research Abstract |
In this study, HTLV-1-negative normal human peripheral blood mononuclear cells(PBMCs) were transplanted directly into the spleens of NOD/SCID/γCnull(NOG) mice together with mitomycin treated HTLV-1-infected cell line. We demonstrated that the both human CD4 and CD8 positive T cells were infected with HTLV-1, and that Tax expression was induced by short time(6hrs) in vitro cultivation, as observed in naturally infected T-cells. Moreover, viral gene expression was also very similar to those observed in naturally infected T-cells. Our method provides a simple, rapid and effective approach for assessment of HTLV-1 infection in vivo ; it is therefore useful in the study of infection, pathogenesis and immunotherapies.
|
Report
(4 results)
Research Products
(32 results)